Following a landmark agreement with the United Kingdom aimed at curbing pharmaceutical costs, the White House is now urging other countries to follow suit by agreeing to pay more for prescription drugs. This shift marks a notable departure from traditional U.S. policy, which has long advocated for lower drug prices globally. As the administration seeks to recalibrate international pricing dynamics, policymakers and industry stakeholders are closely watching how this strategy could reshape the global pharmaceutical landscape.
After UK Deal White House Urges Global Partners to Increase Pharmaceutical Payments
The White House is intensifying calls for global partners to reassess their pharmaceutical pricing frameworks following a recent agreement with the United Kingdom. U.S. officials emphasize the need for an international alignment that ensures pharmaceutical companies receive fair compensation for their innovations, arguing that underpayment by some nations puts undue financial…
—-
Author : Victoria Jones
Publish date : 2025-12-06 08:23:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
